Atom- and Bond-Based 2D TOMOCOMD-CARDD Approach and Ligand-Based Virtual Screening for the Drug Discovery of New Tyrosinase Inhibitors

Two-dimensional atom- and bond-based TOMOCOMD-CARDD descriptors and linear discriminant analysis (LDA) are used in this report to perform a quantitative structure-activity relationship (QSAR) study of tyrosinase-inhibitory activity. A database of inhibitors of the enzyme is collected for this study, within 246 highly dissimilar molecules presenting antityrosinase activity. In total, 7 discriminant functions are obtained by using the whole set of atom- and bond-based 2D indices. All the LDA-based QSAR models show accuracies above 90% in the training set and values of the Matthews correlation coefficient (C) varying from 0.85 to 0.90. The external validation set shows globally good classifications between 89% and 91% and C values ranging from 0.75 to 0.81. Finally, QSAR models are used in the selection/identification of the 20 new dicoumarins subset to search for tyrosinase inhibitory activity. Theoretical and experimental results show good correspondence between one another. It is important to remark that most compounds in this series exhibit a more potent inhibitory activity against the mushroom tyrosinase enzyme than the reference compound, Kojic acid (IC50 = 16.67 μM), resulting in a novel nucleus base (lead) with antityrosinase activity, and this could serve as a starting point for the drug discovery of novel tyrosinase inhibitor lead compounds. ( Journal of Biomolecular Screening 2008:1014-1024)

[1]  M. Natália D. S. Cordeiro,et al.  Computational chemistry approach for the early detection of drug‐induced idiosyncratic liver toxicity , 2008, J. Comput. Chem..

[2]  Richard A. Johnson,et al.  Applied Multivariate Statistical Analysis , 1983 .

[3]  Francisco Torrens,et al.  TOMOCOMD-CARDD descriptors-based virtual screening of tyrosinase inhibitors: evaluation of different classification model combinations using bond-based linear indices. , 2007, Bioorganic & medicinal chemistry.

[4]  H. Uyama,et al.  Tyrosinase inhibitors from natural and synthetic sources: structure, inhibition mechanism and perspective for the future , 2005, Cellular and Molecular Life Sciences CMLS.

[5]  Francisco Torrens,et al.  Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in ‘in silico’ selection of new lead tyrosinase inhibitors , 2007, J. Comput. Aided Mol. Des..

[6]  Paola Gramatica,et al.  New 3D Molecular Descriptors: The WHIM theory and QSAR Applications , 2002 .

[7]  A. Tropsha,et al.  Beware of q2! , 2002, Journal of molecular graphics & modelling.

[8]  R. Crespo‐Otero,et al.  Chemometric and chemoinformatic analyses of anabolic and androgenic activities of testosterone and dihydrotestosterone analogues. , 2008, Bioorganic & medicinal chemistry.

[9]  Li Zhang,et al.  3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors. , 2007, Bioorganic & medicinal chemistry.

[10]  S. Unger.  Molecular Connectivity in Structure–activity Analysis , 1987 .

[11]  James F Blake,et al.  Integrating cheminformatic analysis in combinatorial chemistry. , 2004, Current opinion in chemical biology.

[12]  J. Alvarez.  High-throughput docking as a source of novel drug leads. , 2004, Current opinion in chemical biology.

[13]  Yovani Marrero Ponce.  Total and local (atom and atom type) molecular quadratic indices: significance interpretation, comparison to other molecular descriptors, and QSPR/QSAR applications. , 2004, Bioorganic & medicinal chemistry.

[14]  Alexander Golbraikh,et al.  Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection , 2002, J. Comput. Aided Mol. Des..

[15]  S. Weisberg.  Plots, transformations, and regression , 1985 .

[16]  A. Baldi,et al.  Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients. , 2000, Anticancer research.

[17]  Roberto Todeschini,et al.  Structure/Response Correlations and Similarity/Diversity Analysis by GETAWAY Descriptors, 1. Theory of the Novel 3D Molecular Descriptors , 2002, J. Chem. Inf. Comput. Sci..

[18]  Francisco Torrens,et al.  Atom, atom-type, and total linear indices of the "molecular pseudograph's atom adjacency matrix": application to QSPR/QSAR studies of organic compounds. , 2004, Molecules.

[19]  Lourdes Santana,et al.  On the applicability of QSAR for recognition of miRNA bioorganic structures at early stages of organism and cell development: embryo and stem cells. , 2007, Bioorganic & medicinal chemistry.

[20]  Jorge Gálvez,et al.  Charge Indexes. New Topological Descriptors , 1994, J. Chem. Inf. Comput. Sci..

[21]  V. Sharma,et al.  Mushroom tyrosinase: recent prospects. , 2003, Journal of agricultural and food chemistry.

[22]  Tomasz Arodz,et al.  Computational methods in developing quantitative structure-activity relationships (QSAR): a review. , 2006, Combinatorial chemistry & high throughput screening.

[23]  Yovani Marrero-Ponce,et al.  Bond-based global and local (bond, group and bond-type) quadratic indices and their applications to computer-aided molecular design. 1. QSPR studies of diverse sets of organic chemicals , 2006, J. Comput. Aided Mol. Des..

[24]  Daniel Vitt,et al.  Virtual high-throughput in silico screening , 2003 .

[25]  A. Mayer.  Polyphenol oxidases in plants and fungi: going places? A review. , 2006, Phytochemistry.

[26]  Jürgen Bajorath,et al.  Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. , 2007, Drug discovery today.

[27]  Paola Gramatica,et al.  Statistically Validated QSARs, Based on Theoretical Descriptors, for Modeling Aquatic Toxicity of Organic Chemicals in Pimephales promelas (Fathead Minnow) , 2005, J. Chem. Inf. Model..

[28]  Peter C. Jurs,et al.  QSARs for 6-Azasteroids as Inhibitors of Human Type 1 5-Reductase: Prediction of Binding Affinity and Selectivity Relative to 3-BHSD , 2001, J. Chem. Inf. Comput. Sci..

[29]  Paola Gramatica,et al.  Principles of QSAR models validation: internal and external , 2007 .

[30]  E Estrada,et al.  In silico studies for the rational discovery of anticonvulsant compounds. , 2000, Bioorganic & medicinal chemistry.

[31]  Hugo Kubinyi,et al.  Chemical similarity and biological activities , 2002 .

[32]  Alexander Golbraikh,et al.  Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.